Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 54 of 1,261
  1. US 12258412

    Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  2. US 12258341

    IRAK degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  3. US 12258366

    Bicyclic heteroaryl compounds and uses thereof

    Revolution Medicines, Inc. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  4. US 12258372

    Recombinant vaccine against Marek's disease and Newcastle disease

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  5. US 12258401

    Anti-CD47 combination therapy

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  6. US 12258627

    Kelch domain containing 7B (KLHDC7B) variants and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  7. US 12258612

    Random heteropolymers preserve protein function in foreign environments

    The Regents of the University of California · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  8. US 12258370

    Betulastatin compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 25, 2025 · Expires Mar 20, 2045

    granted
  9. WO 2025058008

    CONJUGUÉ ANTICORPS-MÉDICAMENT CONTENANT UN COMPOSÉ HÉTÉROCYCLIQUE AYANT POUR ACTIVITÉ L'INDUCTION DE LA DÉCOMPOSITION DE LA PROTÉINE KRAS MUTANTE G12D

    ASTELLAS PHARMA INC [JP] · Granted Mar 20, 2025 · Expires Mar 15, 2045

    granted
  10. US 12251432

    Biomarkers and immunogenic compositions for filarial parasites

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  11. US 12251440

    Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  12. US 12252481

    Anti-viral compounds

    Aligos Therapeutics, Inc. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  13. US 12251458

    Anti-aging preparation for skin and application thereof

    SOUTH CHINA NORMAL UNIVERSITY · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  14. US 12250931

    Genetically modified mouse with a humanized PNPLA3 gene and methods of use

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  15. US 12251417

    Antimicrobial compounds from the genus Delftia

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  16. US 12251397

    Cross-linked hyaluronic acids and combinations with PRP/BMC

    REGEN LAB SA · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  17. US 12251387

    Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  18. US 12251378

    Long-acting local anesthetic formulation

    UNIVERSITY OF CONNECTICUT · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  19. US 12252492

    Substituted fused pyrrolo-diazepinones and uses thereof

    Northwestern University · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  20. US 12252497

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  21. US 12252493

    Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer

    Mirati Therapeutics, Inc. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  22. US 12252488

    HPK1 antagonists and uses thereof

    Nimbus Saturn, Inc. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  23. US 12251472

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  24. US 12251468

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.